Fujirebio Europe

Fujirebio Europe was founded in Japan in 1950. In 1966, we developed the world's first syphilis diagnostic kit (TPHA), which also became the gold standard for syphilis testing. Since then, we have established a legacy of innovation, research and development, manufacturing, and marketing of high-quality in vitro diagnostic solutions on a global scale. In recent years, the acquisitions of Centocor Diagnostics, CanAg Diagnostics, and Innogenetics have further expanded our expertise across various clinical fields. Today, through close collaboration with SRL, Inc., a world-leading commercial laboratory and another subsidiary within the H.U. Group, Fujirebio Europe has strengthened its professionalism and gained richer experience in the diagnostics market.